Skip to main content
Log in

Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Interleukin 1 beta (IL-1 beta) is a polypeptide with pro-inflammatory and immunopotentiating effects in vivo and in vitro. With relevance to rheumatoid arthritis (RA) IL-1 augments release of prostanoids, proteinases and oxygen metabolites and is a potent inducer of bone and cartilage resorption. Although high levels of IL-1 have been found in rheumatoid synovial fluids, intra-individual variation in IL-1 production has made it difficult to correlate these levels with disease activity. To overcome this problem we have studied patients with symmetrical and asymmetrical knee joint inflammation. Local disease activity was documented using Ritchie score and joint circumference; IL-1 beta levels were quantitated in synovial fluid by ELISA. In patients with symmetrical joint involvement almost identical levels of IL-1 beta were detected in the right and left knee joints. In contrast, in patients exhibiting asymmetrical knee joint involvement, IL-1 beta levels in the inflamed joints were significantly higher than in the contralateral joints. The study provides further evidence for the role of IL-1 in the pathogenesis of rheumatoid inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pettipher ER, Higgs GA, Henderson B (1986) Interleukin 1 induced leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 82: 8749–8753

    Google Scholar 

  2. Duff GW (1989) Peptide regulatory factors in non-malignant disease. Lancet II: 1432–1435

    Article  Google Scholar 

  3. Duff GW, Durum SK (1983) The pyrogenic and mitogenic actions of interleukin 1 are related. Nature 304: 449–451

    Article  PubMed  Google Scholar 

  4. Dinarello CA (1984) Interleukin 1 and the pathogenesis of acute phase response. N Engl J Med 311: 1413–1418

    PubMed  Google Scholar 

  5. Dinarello CA (1986) Interleukin 1: amino acid sequence multiple biological activities and comparison with tumour necrosis factor. In: Cruse J, Lewis R (eds) The year in immunology. Karger, Basel, pp 68–89

    Google Scholar 

  6. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG (1983) An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306: 373–380

    Article  Google Scholar 

  7. Dingle JT, Saklatvala J, Hesting RM, Tyler JA, Fell HB, Jubb R (1979) A cartilage catabolic factor from synovium. Biochem J 184: 177–180

    PubMed  Google Scholar 

  8. Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW (1988) Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet II: 706–709

    Article  Google Scholar 

  9. Duff GW, Dickens E, Wood N, Manson J, Symons J, Poole S, di Giovine F (1988) Immunoassay, bioassay and in situ hybridization of monokines in human arthritis. In: Oppenheim JJ, Dinarello CA, Kluger M (eds) Progress in leukocyte biology. Liss, New York, pp 387–392

    Google Scholar 

  10. Di Giovine FS, Poole SH, Situnayake RD, Wadhwa M, Duff GW (1990) Absence of correlations between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases. Rheumatol Int 9: 259–264

    Article  PubMed  Google Scholar 

  11. Ritchie DM, Boyle JA, McInnes JM, Jasomi MK, Dalakos TG, Grieveson P, Buchanan WW (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 393–406

    PubMed  Google Scholar 

  12. Rooney M, Whelan A, Feighery C, Bresnihan B (1989) The immunohistologic features of synovitis, disease activity and in vitro IgM rheumatoid factor synthesis by blood mononuclear cells in rheumatoid arthritis. J Rheumatol 16: 459–467

    PubMed  Google Scholar 

  13. Symons JA, Wood NC, di Giovine FS, Duff GW (1988) Soluble IL-2 receptor in rheumatoid arthritis: correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol 141: 2612–2618

    PubMed  Google Scholar 

  14. Symons JA, McDowell TL, di Giovine FS, Wood NC, Capper SJ, Duff GW (1989) Interleukin-1 in rheumatoid arthritis: potentiation of immune responses within the joint. Lymphokine Res 8: 365–372

    PubMed  Google Scholar 

  15. March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, Gillis S, Henney C, Kronheim SR, Grabstein K, Conlon PJ, Hopp TP, Cosman D (1985) Cloning sequence and expression of two distinct human interleukin 1 complementary DNAs. Nature 315: 641–647

    Article  PubMed  Google Scholar 

  16. Miossec P, Dinarello CA, Ziff M (1986) Interleukin 1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 29: 461–470

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rooney, M., Symons, J.A. & Duff, G.W. Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 10, 217–219 (1990). https://doi.org/10.1007/BF02274836

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02274836

Key words

Navigation